
Q4 2025 Investor Audibles: Laughing Water Capital, Plural Investing, Kathmandu Capital
Value Hive Podcast
00:00
Liquidea: approval, patents, upside
Discussion of Liquidea's Eutrepia launch, patent battles with United Therapeutics, and upside/downside scenarios.
Play episode from 14:37
Transcript


